Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 3101-3120 of 3,170 trials

Memantine Therapy in Amyotrophic Lateral Sclerosis

NCT01020331

Tau, a protein in the cerebrospinal fluid CSF is believed to be elevated in amyotrophic lateral sclerosis (ALS) patients. The investigators believe that Tau is truly a marker of increased neuronal death from any disease process. It is been shown that Memantine can inhibit and reverse the abnormal hyperphosphorylation of Tau and therefore the investigators are looking at the efficacy of Memantine at 10 mg twice a day (BID) to see if disease progression correlates with possible changes in Tau in ALS patients based on ALS Functional Rating Scale (ALSFRS) scores.

Amyotrophic Lateral Sclerosis

Phoenix Neurological Associates, LTD20 participantsStarted Jun 2005

Phoenix, Arizona, United States

TERMINATEDNA< 1 mile

Prime Time for Superficial Femoral Artery (SFA) - The SFA Study

NCT00902317

The purpose of this study is to compare the different endovascular treatment modalities for the femoropopliteal segment, and to determine technical success, efficacy and patency at mid-term follow-up. Modalities include; Angioplasty/stent (Control group, Guidant), Cryoplasty/stent (Boston Scientific), Laser Angioplasty/stent (Spectranetics), SilverHawk Atherectomy/stent (Fox Hollow), and Viabahn Endograft (WL Gore).

Peripheral Vascular Disease

Arizona Heart Institute130 participantsStarted Nov 2004

Phoenix, Arizona, United States

Memantine Therapy in Amyotrophic Lateral Sclerosis

Prime Time for Superficial Femoral Artery (SFA) - The SFA Study

Rheumatoid Arthritis Trials in Other Cities

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder

A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis

Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia

Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Efficacy of SNX-1012 in the Treatment of Oral Mucositis

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

Basiliximab in Moderate to Severe Ulcerative Colitis

Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

Treatment of Youth With ADHD and Anxiety

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1

Other Conditions in Phoenix